Consolidation with bortezomib and lenalidomide post-ASCT without dexamethasone and bisphosphonates: final analysis of a prospective study in newly diagnosed myeloma patients
Consolidation with bortezomib and lenalidomide post-ASCT without dexamethasone and bisphosphonates: final analysis of a prospective study in newly diagnosed myeloma patients
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2016
Συγγραφείς:
Terpos, E Kastritis, E Christoulas, D Eleutherakis-Papaiakovou, E Gavriatopoulou, M Fotiou, D Panagiotidis, I Ziogas, D Kafantari, E Migkou, M others